Drug Shortage Report for APO-HYDROXYUREA

Last updated on 2020-11-18 History
Report ID 122276
Drug Identification Number 02247937
Brand name APO-HYDROXYUREA
Common or Proper name HYDROXYUREA
Company Name APOTEX INC
Market Status MARKETED
Active Ingredient(s) HYDROXYUREA
Strength(s) 500MG
Dosage form(s) CAPSULE CAPSULE
Route of administration ORAL ORAL
Packaging size 100 BTL
ATC code L01XX
ATC description OTHER ANTINEOPLASTIC AGENTS
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2020-08-10
Estimated end date 2020-11-16
Actual end date 2020-11-17
Shortage status Resolved
Updated date 2020-11-18
Company comments Allocating the limited inventory
Health Canada comments
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v5 2020-11-18 French Compare
v4 2020-11-18 English Compare
v3 2020-08-14 French Compare
v2 2020-08-14 English Compare
v1 2020-08-14 English Compare